If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 </stron ...

The US Food and Drug Administration (FDA) has accepted for priority review the supplemental biologics license application (sBLA) for Dupixent (dupilumab) to treat adults with bullous pemphigoid (BP).

If approved, Dupixent would be the first and only targeted medicine to treat BP in the U.S.; FDA decision expected by June 20, 2025 Priority Review granted based on positive pivotal results demonstrat ...

It’s normal to have lots of questions when you start a new prescription medication. Whether you can drink alcohol might be at ...

As an avid runner, I've always struggled with neck and shoulder tension after long training sessions. No matter how much I stretched or tried to improve my form, that nagging tightness seemed to ...

Doctors say women tend to ignore a lot of signs and symptoms indicating serious health risks. Here is a comprehensive guide ...

Gargling is a well-known and easy method to keep your throat healthy, particularly during the cold and flu season. However, ...

Major League Baseball season is upon us at long last. Though the Hot Stove flame still flickers while teams look to tweak ...